Mega Lifesciences PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,273	3,463	2,357	2,453	2,198
Short-Term Investments	370.96	395.19	365.05	345.55	342.64
Cash & Short-Term Investments	4,644	3,858	2,722	2,799	2,540
Cash Growth	20.37%	41.74%	-2.76%	10.18%	106.14%
Accounts Receivable	3,306	2,975	3,314	3,107	2,557
Other Receivables	143.66	152.53	158.28	180.15	164.18
Receivables	3,450	3,128	3,472	3,287	2,721
Inventory	3,038	3,033	3,377	4,109	3,823
Prepaid Expenses	58.79	60.43	58.59	60.14	53.43
Other Current Assets	162.24	147.7	360.23	334.95	162.8
Total Current Assets	11,353	10,227	9,990	10,590	9,301
Property, Plant & Equipment	2,409	2,213	2,225	2,151	2,103
Long-Term Investments	37.22	40.39	221.15	222.88	214.79
Goodwill	428.51	449	456.24	465.88	476.25
Other Intangible Assets	867.17	869.72	862.23	863.31	876.89
Long-Term Deferred Tax Assets	375.3	299.89	278.95	250.32	210.41
Other Long-Term Assets	289.03	111.52	81	103.49	89.75
Total Assets	15,759	14,210	14,115	14,646	13,272
Accounts Payable	1,720	1,685	1,925	2,793	2,527
Accrued Expenses	1,096	1,102	1,140	1,604	1,283
Short-Term Debt	472.24	287.58	76	229.18	168.18
Current Portion of Leases	65.1	63.83	43.78	82.96	56.21
Current Income Taxes Payable	323.29	145.54	108.45	204.18	185.86
Other Current Liabilities	1,419	630.65	1,133	624.44	633.02
Total Current Liabilities	5,096	3,914	4,427	5,538	4,853
Long-Term Leases	146.2	139.83	132.06	108.73	131.94
Pension & Post-Retirement Benefits	300.98	278.11	251.91	222.94	261.28
Long-Term Deferred Tax Liabilities	0.6	1.05	2.14	-	-
Total Liabilities	5,544	4,333	4,813	5,870	5,247
Common Stock	435.94	435.94	435.94	435.94	435.94
Additional Paid-In Capital	2,305	2,305	2,305	2,305	2,305
Retained Earnings	8,353	7,830	7,210	6,655	5,766
Comprehensive Income & Other	-878.11	-693.31	-648.11	-618.9	-503.97
Total Common Equity	10,215	9,877	9,302	8,777	8,003
Minority Interest	0.03	0.08	0.02	0.07	22.3
Shareholders' Equity	10,215	9,877	9,302	8,777	8,025
Total Liabilities & Equity	15,759	14,210	14,115	14,646	13,272
Total Debt	683.54	491.24	251.84	420.87	356.33
Net Cash (Debt)	3,960	3,367	2,470	2,378	2,184
Net Cash Growth	17.63%	36.31%	3.86%	8.89%	273.44%
Net Cash Per Share	4.54	3.86	2.83	2.73	2.50
Filing Date Shares Outstanding	871.87	871.87	871.87	871.87	871.87
Total Common Shares Outstanding	871.87	871.87	871.87	871.87	871.87
Working Capital	6,256	6,312	5,563	5,052	4,448
Book Value Per Share	11.72	11.33	10.67	10.07	9.18
Tangible Book Value	8,920	8,558	7,984	7,447	6,650
Tangible Book Value Per Share	10.23	9.82	9.16	8.54	7.63

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.